or Try an Advanced Search...

    Solid Tumors Stocks List

    Symbol Grade Name % Change
    FUSN A Fusion Pharmaceuticals Inc. 0.23
    XOMA B XOMA Corporation 2.18
    MRUS B Merus N.V. -7.09
    ONCT B Oncternal Therapeutics, Inc. 1.21
    LYEL B Lyell Immunopharma, Inc. 4.14
    HALO C Halozyme Therapeutics, Inc. 2.17
    LGND C Ligand Pharmaceuticals Incorporated 1.30
    TCRX C TScan Therapeutics, Inc. 3.14
    KURA C Kura Oncology, Inc. -0.39
    CGEM C Cullinan Management, Inc. 3.12
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Long-Term Care Facilities Medical Devices Other Shell Companies
    Related Stock Lists: Cancer Biopharmaceutical Clinical Medicine Medicine Cancer Treatment Clinical Development Immunotherapy Biotechnology Immune System Ovarian Cancer Treatment Of Cancer Advanced Non Small Cell Lung Cancer Antineoplastic Drugs Bladder Cancer Blastoma Breast Cancer Cancer Cell Cancer Immunotherapy Checkpoint Inhibitor Drugs

    Related ETFs - A few ETFs which own one or more of the above listed Solid Tumors stocks.

    Symbol Grade Name Weight
    PBE C PowerShares Dynamic Biotech & Genome 2.58
    IDNA C iShares Genomics Immunology and Healthcare ETF 2.39
    BBC D Virtus LifeSci Biotech Clinical Trials ETF 1.97
    WDNA D WisdomTree BioRevolution Fund 1.89
    SBIO D ALPS Medical Breakthroughs ETF 1.63
    View all Solid Tumors ETFs...
    Compare ETFs
    Compare IDNA to WDNA Compare PBE to SBIO Compare PBE to WDNA

        Solid Tumors Stocks Recent News

        Date Stock Title
        May 31 FUSN Ontario court approves AstraZeneca/Fusion acquisition plan
        May 31 FUSN Fusion Pharmaceuticals Receives Final Court Order Approving Arrangement
        May 30 ONCT Oncternal Announces Enrollment Completed and Dosing Initiated for Fifth Dose Cohort of Phase 1/2 Study of ONCT-534 for the Treatment of R/R Metastatic Castration-Resistant Prostate Cancer
        May 30 TCRX TScan Therapeutics Announces Upcoming Presentation at the Jefferies Global Healthcare Conference
        May 30 MRUS Merus announces pricing of upsized public offering of common shares
        May 30 MRUS Merus Announces Pricing of Upsized Public Offering of Common Shares
        May 29 FUSN Fusion shareholders give green light to AstraZeneca acquisition
        May 29 FUSN Fusion Pharmaceuticals Shareholders Approve Acquisition by AstraZeneca
        May 29 MRUS These Analysts Think Merus N.V.'s (NASDAQ:MRUS) Sales Are Under Threat
        May 29 MRUS Merus to Participate in a Fireside Chat at the Jefferies Global Healthcare Conference
        May 29 KURA Kura Oncology to Participate in Jefferies Global Healthcare Conference
        May 29 TCRX TScan Therapeutics Receives FDA’s Regenerative Medicine Advanced Therapy (RMAT) Designation for its Two Lead TCR-T Therapy Candidates for the Treatment of Heme Malignancies
        May 28 MRUS Merus announces proposed public offering of common shares
        May 28 MRUS Merus N.V. Announces Proposed Public Offering of Common Shares
        May 28 MRUS Merus’ Petosemtamab in Combination with Pembrolizumab Interim Data Demonstrates Robust Response Rate and Favorable Safety Profile in 1L r/m HNSCC
        May 27 MRUS Merus (MRUS) Surges 36% on Head & Neck Cancer Antibody Data
        Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Long-Term Care Facilities Medical Devices Other Shell Companies
        Related Stock Lists: Cancer Biopharmaceutical Clinical Medicine Medicine Cancer Treatment Clinical Development Immunotherapy Biotechnology Immune System Ovarian Cancer Treatment Of Cancer Advanced Non Small Cell Lung Cancer Antineoplastic Drugs Bladder Cancer Blastoma Breast Cancer Cancer Cell Cancer Immunotherapy Checkpoint Inhibitor Drugs
        Solid Tumors

        Solid tumors are masses of abnormal cells that form when cells in the body divide and grow uncontrollably. They are usually found in the organs, but can also form in the tissues of the body. Solid tumors can be benign (non-cancerous) or malignant (cancerous).

        Browse All Tags